View in EDS

Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.

Saved in:
Bibliographic Details
Title: Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.
Authors: Remon, J.1 (AUTHOR), Besse, B.1 (AUTHOR), Aix, S. Ponce2 (AUTHOR), Callejo, A.3 (AUTHOR), Al-Rabi, K.4 (AUTHOR), Bernabe, R.5 (AUTHOR), Greillier, L.6 (AUTHOR), Majem, M.7 (AUTHOR), Reguart, N.8 (AUTHOR), Monnet, I.9 (AUTHOR), Cousin, S.10 (AUTHOR), Garrido, P.11 (AUTHOR), Robinet, G.12 (AUTHOR), Garcia Campelo, R.13 (AUTHOR), Madroszyk, A.14 (AUTHOR), Mazières, J.15 (AUTHOR), Curcio, H.16 (AUTHOR), Wasąg, B.17 (AUTHOR), Pretzenbacher, Y.18 (AUTHOR), Fournier, B.18 (AUTHOR)
Source: Annals of Oncology. May2023, Vol. 34 Issue 5, p468-476. 9p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 163427905
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Remon%2C+J%2E%22">Remon, J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Besse%2C+B%2E%22">Besse, B.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aix%2C+S%2E+Ponce%22">Aix, S. Ponce</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Callejo%2C+A%2E%22">Callejo, A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Al-Rabi%2C+K%2E%22">Al-Rabi, K.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bernabe%2C+R%2E%22">Bernabe, R.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Greillier%2C+L%2E%22">Greillier, L.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Majem%2C+M%2E%22">Majem, M.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Reguart%2C+N%2E%22">Reguart, N.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Monnet%2C+I%2E%22">Monnet, I.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cousin%2C+S%2E%22">Cousin, S.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garrido%2C+P%2E%22">Garrido, P.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Robinet%2C+G%2E%22">Robinet, G.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garcia+Campelo%2C+R%2E%22">Garcia Campelo, R.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Madroszyk%2C+A%2E%22">Madroszyk, A.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mazières%2C+J%2E%22">Mazières, J.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Curcio%2C+H%2E%22">Curcio, H.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wasąg%2C+B%2E%22">Wasąg, B.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pretzenbacher%2C+Y%2E%22">Pretzenbacher, Y.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fournier%2C+B%2E%22">Fournier, B.</searchLink><relatesTo>18</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. May2023, Vol. 34 Issue 5, p468-476. 9p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=163427905
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2023.02.012
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 468
    Titles:
      – TitleFull: Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Remon, J.
      – PersonEntity:
          Name:
            NameFull: Besse, B.
      – PersonEntity:
          Name:
            NameFull: Aix, S. Ponce
      – PersonEntity:
          Name:
            NameFull: Callejo, A.
      – PersonEntity:
          Name:
            NameFull: Al-Rabi, K.
      – PersonEntity:
          Name:
            NameFull: Bernabe, R.
      – PersonEntity:
          Name:
            NameFull: Greillier, L.
      – PersonEntity:
          Name:
            NameFull: Majem, M.
      – PersonEntity:
          Name:
            NameFull: Reguart, N.
      – PersonEntity:
          Name:
            NameFull: Monnet, I.
      – PersonEntity:
          Name:
            NameFull: Cousin, S.
      – PersonEntity:
          Name:
            NameFull: Garrido, P.
      – PersonEntity:
          Name:
            NameFull: Robinet, G.
      – PersonEntity:
          Name:
            NameFull: Garcia Campelo, R.
      – PersonEntity:
          Name:
            NameFull: Madroszyk, A.
      – PersonEntity:
          Name:
            NameFull: Mazières, J.
      – PersonEntity:
          Name:
            NameFull: Curcio, H.
      – PersonEntity:
          Name:
            NameFull: Wasąg, B.
      – PersonEntity:
          Name:
            NameFull: Pretzenbacher, Y.
      – PersonEntity:
          Name:
            NameFull: Fournier, B.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1